journal
https://read.qxmd.com/read/38610045/statin-use-as-a-moderator-on-the-association-between-metformin-and-breast-cancer-risk-in-women-with-type-2-diabetes-mellitus
#1
JOURNAL ARTICLE
Fan Zhang, Geertruida H de Bock, Gijs W Landman, Qingying Zhang, Grigory Sidorenkov
INTRODUCTION: Metformin and statins are considered as potential agents for prevention of breast cancer, however, existing evidence does not uniformly substantiate this claim, and the data is scarce concerning their interaction in relation to breast cancer risk. This study aims to investigate whether the effect of metformin on breast cancer incidence varied by statin use among women with type 2 diabetes mellitus (T2DM). METHODS: This study included women with T2DM, without a history of cancers, and followed up for more than one year from the Zwolle Outpatient Diabetes project Integrating Available Care (ZODIAC) for the period 1998-2014...
April 12, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38594734/purine-salvage-promotes-treatment-resistance-in-h3k27m-mutant-diffuse-midline-glioma
#2
JOURNAL ARTICLE
Erik R Peterson, Peter Sajjakulnukit, Andrew J Scott, Caleb Heaslip, Anthony Andren, Kari Wilder-Romans, Weihua Zhou, Sravya Palavalasa, Navyateja Korimerla, Angelica Lin, Alexandra O'Brien, Ayesha Kothari, Zitong Zhao, Li Zhang, Meredith A Morgan, Sriram Venneti, Carl Koschmann, Nada Jabado, Costas A Lyssiotis, Maria G Castro, Daniel R Wahl
BACKGROUND: Diffuse midline gliomas (DMG), including diffuse intrinsic pontine gliomas (DIPGs), are a fatal form of brain cancer. These tumors often carry a driver mutation on histone H3 converting lysine 27 to methionine (H3K27M). DMG-H3K27M are characterized by altered metabolism and resistance to standard of care radiation (RT) but how the H3K27M mediates the metabolic response to radiation and consequent treatment resistance is uncertain. METHODS: We performed metabolomics on irradiated and untreated H3K27M isogenic DMG cell lines and observed an H3K27M-specific enrichment for purine synthesis pathways...
April 9, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38532464/bcaa-metabolism-in-pancreatic-cancer-affects-lipid-balance-by-regulating-fatty-acid-import-into-mitochondria
#3
JOURNAL ARTICLE
Klára Gotvaldová, Jitka Špačková, Jiří Novotný, Kamila Baslarová, Petr Ježek, Lenka Rossmeislová, Jan Gojda, Katarína Smolková
BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) has been associated with the host dysmetabolism of branched-chain amino acids (BCAAs), however, the implications for the role of BCAA metabolism in PDAC development or progression are not clear. The mitochondrial catabolism of valine, leucine, and isoleucine is a multistep process leading to the production of short-chain R-CoA species. They can be subsequently exported from mitochondria as short-chain carnitines (SC-CARs), utilized in anabolic pathways, or released from the cells...
March 26, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38515202/serine-synthesis-and-catabolism-in-starved-lung-cancer-and-primary-bronchial-epithelial-cells
#4
JOURNAL ARTICLE
Theresa Haitzmann, Katharina Schindlmaier, Tobias Frech, Ayusi Mondal, Visnja Bubalo, Barbara Konrad, Gabriele Bluemel, Philipp Stiegler, Stefanie Lackner, Andelko Hrzenjak, Thomas Eichmann, Harald C Köfeler, Katharina Leithner
Serine and glycine give rise to important building blocks in proliferating cells. Both amino acids are either synthesized de novo or taken up from the extracellular space. In lung cancer, serine synthesis gene expression is variable, yet, expression of the initial enzyme, phosphoglycerate dehydrogenase (PHGDH), was found to be associated with poor prognosis. While the contribution of de novo synthesis to serine pools has been shown to be enhanced by serine starvation, the impact of glucose deprivation, a commonly found condition in solid cancers is poorly understood...
March 21, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38500219/dietary-patterns-in-relation-to-glioma-a-case-control-study
#5
JOURNAL ARTICLE
Mohammad Nemati, Mehdi Shayanfar, Fatemeh Almasi, Minoo Mohammad-Shirazi, Giuve Sharifi, Azadeh Aminianfar, Ahmad Esmaillzadeh
Although the association of individual foods and nutrients with glioma have been investigated, studies on the association of major dietary patterns and glioma are scarce. The aim of this study was to examine the association between major dietary patterns and risk of glioma in a group of Iranian adults. In this hospital-based case-control design, we recruited 128 newly diagnosed glioma cases and 256 controls in Tehran from 2009 to 2011. A Willett-format-validated 126-item semi-quantitative Food Frequency Questionnaire (FFQ) was used to assess participants' dietary intake...
March 18, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38395945/elevated-expression-of-higd1a-drives-hepatocellular-carcinoma-progression-by-regulating-polyamine-metabolism-through-c-myc-odc1-nexus
#6
JOURNAL ARTICLE
Haixing Zhang, Xiaoran Li, Ziying Liu, Zimo Lin, Kuiyuan Huang, Yiran Wang, Yu Chen, Leyi Liao, Leyuan Wu, Zhanglian Xie, Jinlin Hou, Xiaoyong Zhang, Hongyan Liu
BACKGROUND: Hypoxia contributes to cancer progression through various molecular mechanisms and hepatocellular carcinoma (HCC) is one of the most hypoxic malignancies. Hypoxia-inducible gene domain protein-1a (HIGD1A) is typically induced via epigenetic regulation and promotes tumor cell survival during hypoxia. However, the role of HIGD1A in HCC remains unknown. METHODS: HIGD1A expression was determined in 24 pairs of human HCC samples and para-tumorous tissues...
February 23, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38365771/high-fat-diet-promotes-prostate-cancer-metastasis-via-rps27
#7
JOURNAL ARTICLE
Dameng Li, Xueying Zhou, Wenxian Xu, Yongxin Cai, Chenglong Mu, Xinchun Zhao, Tingting Tang, Chen Liang, Tao Yang, Junnian Zheng, Liang Wei, Bo Ma
BACKGROUND: Metastasis is the leading cause of death among prostate cancer (PCa) patients. Obesity is associated with both PCa-specific and all-cause mortality. High-fat diet (HFD) is a risk factor contributing to obesity. However, the association of HFD with PCa metastasis and its underlying mechanisms are unclear. METHODS: Tumor xenografts were conducted by intrasplenic injections. The ability of migration or invasion was detected by transwell assay. The expression levels of RPS27 were detected by QRT-PCR and western blot...
February 16, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38350962/cone-photoreceptor-phosphodiesterase-pde6h-inhibition-regulates-cancer-cell-growth-and-metabolism-replicating-the-dark-retina-response
#8
JOURNAL ARTICLE
Ceren Yalaz, Esther Bridges, Nasullah K Alham, Christos E Zois, Jianzhou Chen, Karim Bensaad, Ana Miar, Elisabete Pires, Ruth J Muschel, James S O McCullagh, Adrian L Harris
BACKGROUND: PDE6H encodes PDE6γ', the inhibitory subunit of the cGMP-specific phosphodiesterase 6 in cone photoreceptors. Inhibition of PDE6, which has been widely studied for its role in light transduction, increases cGMP levels. The purpose of this study is to characterise the role of PDE6H in cancer cell growth. METHODS: From an siRNA screen for 487 genes involved in metabolism, PDE6H was identified as a controller of cell cycle progression in HCT116 cells...
February 13, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38317210/circulating-metabolome-landscape-in-lynch-syndrome
#9
JOURNAL ARTICLE
Tiina A Jokela, Jari E Karppinen, Minta Kärkkäinen, Jukka-Pekka Mecklin, Simon Walker, Toni T Seppälä, Eija K Laakkonen
Circulating metabolites systemically reflect cellular processes and can modulate the tissue microenvironment in complex ways, potentially impacting cancer initiation processes. Genetic background increases cancer risk in individuals with Lynch syndrome; however, not all carriers develop cancer. Various lifestyle factors can influence Lynch syndrome cancer risk, and lifestyle choices actively shape systemic metabolism, with circulating metabolites potentially serving as the mechanical link between lifestyle and cancer risk...
February 5, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38273418/systemic-inflammation-and-insulin-resistance-related-indicator-predicts-poor-outcome-in-patients-with-cancer-cachexia
#10
JOURNAL ARTICLE
Guo-Tian Ruan, Li Deng, Hai-Lun Xie, Jin-Yu Shi, Xiao-Yue Liu, Xin Zheng, Yue Chen, Shi-Qi Lin, He-Yang Zhang, Chen-An Liu, Yi-Zhong Ge, Meng-Meng Song, Chun-Lei Hu, Xiao-Wei Zhang, Ming Yang, Wen Hu, Ming-Hua Cong, Li-Chen Zhu, Kun-Hua Wang, Han-Ping Shi
BACKGROUND: The C-reactive protein (CRP)-triglyceride-glucose (TyG) index (CTI), which is a measure representing the level of inflammation and insulin resistance (IR), is related to poor cancer prognosis; however, the CTI has not been validated in patients with cancer cachexia. Thus, this study aimed to explore the potential clinical value of the CTI in patients with cancer cachexia. METHODS: In this study, our prospective multicenter cohort included 1411 patients with cancer cachexia (mean age 59...
January 25, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38200513/deficiency-of-top1mt-enhances-glycolysis-through-the-stimulation-of-pdk4-expression-in-gastric-cancer
#11
JOURNAL ARTICLE
Hongqiang Wang, Xutao Sun, Chen Yang, Ziqi Li, Danwen Jin, Wenwen Zhu, Ze Yu
BACKGROUND: Abnormal glucose metabolism is one of the determinants of maintaining malignant characteristics of cancer. Targeting cancer metabolism is regarded as a new strategy for cancer treatment. Our previous studies have found that TOP1MT is a crucial gene that inhibits glycolysis and cell metastasis of gastric cancer (GC) cells, but the mechanism of its regulation of glycolysis remains unclear. METHODS: Transcriptome sequencing data, clinic-pathologic features of GC from a variety of public databases, and WGCNA were used to identify novel targets of TOP1MT...
January 10, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38167536/assessment-of-lipolysis-biomarkers-in-adipose-tissue-of-patients-with-gastrointestinal-cancer
#12
JOURNAL ARTICLE
Federica Tambaro, Giovanni Imbimbo, Elisabetta Ferraro, Martina Andreini, Roberta Belli, Maria Ida Amabile, Cesarina Ramaccini, Giulia Lauteri, Giuseppe Nigri, Maurizio Muscaritoli, Alessio Molfino
BACKGROUND: Adipose tissue metabolism may be impaired in patients with cancer. In particular, increased lipolysis was described in cancer-promoting adipose tissue atrophy. For this reason, we assessed the expression of the lipolysis-associated genes and proteins in subcutaneous adipose tissue (SAT) of gastrointestinal (GI) cancer patients compared to controls to verify their involvement in cancer, among different types of GI cancers, and in cachexia. METHODS: We considered patients with GI cancer (gastric, pancreatic, and colorectal) at their first diagnosis, with/without cachexia, and controls with benign diseases...
January 2, 2024: Cancer & Metabolism
https://read.qxmd.com/read/38111065/steap4-inhibits-cisplatin-induced-chemotherapy-resistance-through-suppressing-pi3k-akt-in-hepatocellular-carcinoma
#13
JOURNAL ARTICLE
Binhui Xie, Baiyin Zhong, Zhenxian Zhao, Jie Hu, Jianqiong Yang, Yuankang Xie, Jianhong Zhang, Jianting Long, Xuewei Yang, Heping Li
Chemotherapy resistance is the leading cause for hepatocellular carcinoma (HCC)-induced death. Exploring resistance generation mechanism is an urgent need for HCC therapy. Here, we found STEAP4 was significantly downregulated in HCC patients with recurrence. Patients with low STEAP4 had poor outcome, suggesting STEAP4 might inhibit chemotherapy resistance. Cell viability assay, colony formation assay, apoptosis assay, soft agar growth assay, and tumor animal model showed STEAP4 inhibited cisplatin resistance...
December 18, 2023: Cancer & Metabolism
https://read.qxmd.com/read/38111012/a-feedback-loop-of-ppp-and-pi3k-akt-signal-pathway-drives-regorafenib-resistance-in-hcc
#14
JOURNAL ARTICLE
Huihua Yang, Dahong Chen, Yafei Wu, Heming Zhou, Wenjing Diao, Gaolin Liu, Qin Li
BACKGROUND: Hepatocellular carcinoma (HCC) is a principal type of liver cancer with high incidence and mortality rates. Regorafenib is a novel oral multikinase inhibitor for second-line therapy for advanced HCC. However, resistance to regorafenib is gradually becoming a dilemma for HCC and the mechanism remains unclear. In this study, we aimed to reveal the metabolic profiles of regorafenib-resistant cells and the key role and mechanism of the most relevant metabolic pathway in regorafenib resistance...
December 18, 2023: Cancer & Metabolism
https://read.qxmd.com/read/38066600/a-hif-1%C3%AE-inhibitor-combined-with-palmitic-acid-and-l-carnitine-treatment-can-prevent-the-fat-metabolic-reprogramming-under-hypoxia-and-induce-apoptosis-in-hepatocellular-carcinoma-cells
#15
JOURNAL ARTICLE
Shohei Matsufuji, Yoshihiko Kitajima, Kazuki Higure, Naoya Kimura, Sachiko Maeda, Kohei Yamada, Kotaro Ito, Tomokazu Tanaka, Keita Kai, Hirokazu Noshiro
BACKGROUND: A hypoxic environment often persists within solid tumors, including hepatocellular carcinoma (HCC). Hypoxia-inducible factor-1α (HIF-1α) can accelerate cancer malignancy by inducing hypoxia-dependent expression of various genes. Tumor hypoxia can also induce metabolic reprogramming of fatty acid (FA) metabolism, through which HIF-1α plays an essential role in diminishing fatty acid β-oxidation (FAO) in hypoxic cancer cells. METHODS: We aimed to investigate potential new drug therapy options for targeting hypoxic cancer cells within HCC tumors, specifically through combining HIF-1α inhibition with palmitic acid (PA) + L-carnitine (LC) treatment to effectively induce apoptosis in hypoxic HCC cells...
December 8, 2023: Cancer & Metabolism
https://read.qxmd.com/read/38057929/the-classification-of-obesity-based-on-metabolic-status-redefines-the-readmission-of-non-hodgkin-s-lymphoma-an-observational-study
#16
JOURNAL ARTICLE
Hang Dong, Honglin Guo, Jing Du, Yiping Cheng, Dawei Wang, Junming Han, Zinuo Yuan, Zhenyu Yao, Ran An, Xiaoqin Wu, Kyle L Poulsen, Zhixiang Wang, Shanshan Shao, Xiude Fan, Zhen Wang, Jiajun Zhao
BACKGROUND: The relationship between obesity and non-Hodgkin's lymphoma (NHL) was controversial, which may be due to the crudeness definition of obesity based on body mass index (BMI). As obesity and metabolic abnormalities often coexist, we aimed to explore whether the classification of obesity based on metabolic status can help to evaluate the real impact of obesity on the readmission of NHL. METHODS: In this retrospective cohort study, utilizing the 2018 Nationwide Readmissions Database, we identified NHL-related index hospitalizations and followed them for non-elective readmission...
December 6, 2023: Cancer & Metabolism
https://read.qxmd.com/read/38053135/metabolic-changes-preceding-bladder-cancer-occurrence-among-korean-men-a-nested-case-control-study-from-the-kcps-ii-cohort
#17
JOURNAL ARTICLE
Youngmin Han, Unchong Kim, Keum Ji Jung, Ji-Young Lee, Kwangbae Lee, Sang Yop Shin, Heejin Kimm, Sun Ha Jee
BACKGROUND: Bladder cancer (BLCA) research in Koreans is still lacking, especially in focusing on the prediction of BLCA. The current study aimed to discover metabolic signatures related to BLCA onset and confirm its potential as a biomarker. METHODS: We designed two nested case-control studies using Korean Cancer Prevention Study (KCPS)-II. Only males aged 35-69 were randomly selected and divided into two sets by recruitment organizations [set 1, BLCA (n = 35) vs...
December 5, 2023: Cancer & Metabolism
https://read.qxmd.com/read/37957679/autofluorescence-imaging-of-endogenous-metabolic-cofactors-in-response-to-cytokine-stimulation-of-classically-activated-macrophages
#18
JOURNAL ARTICLE
Shelby N Bess, Matthew J Igoe, Abby C Denison, Timothy J Muldoon
BACKGROUND: Macrophages are one of the most prevalent subsets of immune cells within the tumor microenvironment and perform a range of functions depending on the cytokines and chemokines released by surrounding cells and tissues. Recent research has revealed that macrophages can exhibit a spectrum of phenotypes, making them highly plastic due to their ability to alter their physiology in response to environmental cues. Recent advances in examining heterogeneous macrophage populations include optical metabolic imaging, such as fluorescence lifetime imaging (FLIM), and multiphoton microscopy...
November 13, 2023: Cancer & Metabolism
https://read.qxmd.com/read/37946297/the-effects-of-chemotherapy-on-resting-energy-expenditure-body-composition-and-cancer-related-fatigue-in-women-with-breast-cancer-a-prospective-cohort-study
#19
JOURNAL ARTICLE
Timia Van Soom, Wiebren Tjalma, Konstantinos Papadimitriou, Nick Gebruers, Eric van Breda
BACKGROUND: Breast cancer (BC) is the most prevalent tumor in women. Improvements in treatment led to declined mortality, resulting in more survivors living with cancer- or therapy-induced comorbidities. In this study, we investigated the impact of neoplasia and chemotherapy on resting energy expenditure (REE) and body composition, in relation to cancer-related fatigue. Inflammatory parameters were checked as possible explanation for changes in REE. METHODS: Fifty-six women participated: 20 women with BC and 36 healthy controls...
November 9, 2023: Cancer & Metabolism
https://read.qxmd.com/read/37932830/atm-inhibition-blocks-glucose-metabolism-and-amplifies-the-sensitivity-of-resistant-lung-cancer-cell-lines-to-oncogene-driver-inhibitors
#20
JOURNAL ARTICLE
Cristina Terlizzi, Viviana De Rosa, Francesca Iommelli, Antonio Pezone, Giovanna G Altobelli, Maurizio Maddalena, Jelena Dimitrov, Caterina De Rosa, Carminia Maria Della Corte, Vittorio Enrico Avvedimento, Silvana Del Vecchio
BACKGROUND: ATM is a multifunctional serine/threonine kinase that in addition to its well-established role in DNA repair mechanisms is involved in a number of signaling pathways including regulation of oxidative stress response and metabolic diversion of glucose through the pentose phosphate pathway. Oncogene-driven tumorigenesis often implies the metabolic switch from oxidative phosphorylation to glycolysis which provides metabolic intermediates to sustain cell proliferation. The aim of our study is to elucidate the role of ATM in the regulation of glucose metabolism in oncogene-driven cancer cells and to test whether ATM may be a suitable target for anticancer therapy...
November 6, 2023: Cancer & Metabolism
journal
journal
47877
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.